dactinomycin and exenatide

dactinomycin has been researched along with exenatide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ahn, YB; Chang, SY; Jeong, IK; Jo, YH; Kim, DB; Kim, MJ; Ko, SH; Ryu, GR	1

Reviews

1 review(s) available for dactinomycin and exenatide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for dactinomycin and exenatide

Article	Year
Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway. Journal of cellular biochemistry, 2013, Volume: 114, Issue:4 Topics: 3' Untranslated Regions; Animals; Cell Line; Cyclic AMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Enzyme Stability; Exenatide; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide-1 Receptor; Imines; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Peptides; Promoter Regions, Genetic; Protein Binding; Proteolysis; Receptors, Glucagon; RNA Stability; Venoms	2013

Article

Year

Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway.

Journal of cellular biochemistry, 2013, Volume: 114, Issue:4

Topics: 3' Untranslated Regions; Animals; Cell Line; Cyclic AMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Enzyme Stability; Exenatide; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide-1 Receptor; Imines; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Peptides; Promoter Regions, Genetic; Protein Binding; Proteolysis; Receptors, Glucagon; RNA Stability; Venoms

2013